This inventor holds 3 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Industry-University Cooperation Foundation Hanyang University, Fnct Biotech, Inc. Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 1,248 
1 out of 1 Years Active: 2020-2026
Title: Innovations and Contributions of Inventor Su Jae Lee
Introduction
Su Jae Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the treatment and prevention of diseases such as pulmonary fibrosis and cancer. With a total of 3 patents, his work showcases innovative approaches to medical challenges.
Latest Patents
One of Su Jae Lee's latest patents involves the use of G-CSF antibody for the treatment of pulmonary fibrosis. This patent discloses a new application of M-CSF or G-CSF as a useful marker for diagnosis or treatment of pulmonary fibrosis. The composition contains M-CSF inhibitor and/or G-CSF inhibitor as active ingredients, which are effective in preventing or treating pulmonary fibrosis by significantly inhibiting myofibroblast hyperplasia in pulmonary cells.
Another notable patent focuses on a peptide with anticancer activity. This peptide binds to the transcription factor CP2c and is represented by the sequence Asn-Tyr-Pro-Gln-Arg-Pro. The pharmaceutical composition and dietary supplement composition containing this peptide are designed for preventing and treating cancer. The peptide can effectively pass through the cell membrane and inhibit the DNA binding ability of CP2c, thereby disrupting cancer cell-specific transcriptional activity. This innovation allows for targeted treatment of cancer cells and can be utilized as a dietary supplement.
Career Highlights
Su Jae Lee has worked with notable organizations such as Fnct Biotech, Inc. and the Industry-University Cooperation Foundation at Hanyang University. His experience in these institutions has contributed to his expertise in biotechnology and innovation.
Collaborations
Throughout his career, Su Jae Lee has collaborated with several professionals, including Mi Young Choi and Jae Kyung Myung. These collaborations have further enhanced his research and development efforts in the field.
Conclusion
Su Jae Lee's innovative patents and contributions to biotechnology demonstrate his commitment to advancing medical science. His work in developing treatments for pulmonary fibrosis and cancer highlights the importance of innovation in addressing critical health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile